[{"quiz_id": "ABMS20260101_kimi-k2-thinking_p01", "question_id": "ABMS20260101_kimi-k2-thinking_p01-001", "question": "A 14-month-old boy with genetically confirmed PMM2-CDG (p.Arg141His and p.Phe119Leu compound heterozygous variants) is scheduled for inguinal hernia repair. Preoperative coagulation studies show antithrombin III 45% (normal 80-120%), protein C 38% (normal 70-140%), and protein S 32% (normal 65-140%). All other labs are normal. What is the most appropriate perioperative management to minimize thrombotic risk?", "options": ["Proceed with surgery without prophylaxis; risk is theoretical", "Administer prophylactic enoxaparin 0.5 mg/kg subcutaneously 12 hours preoperatively and postoperatively", "Transfuse fresh frozen plasma to correct factor deficiencies before surgery", "Delay surgery indefinitely until coagulation factors normalize with nutritional support", "Administer antithrombin III concentrate 50 IU/kg immediately preoperatively"], "answer": "B", "answer_index": 1, "explanation": "PMM2-CDG causes combined antithrombin III, protein C, and protein S deficiency, creating significant thrombotic risk. For surgical prophylaxis, LMWH is recommended to address all deficient pathways. FFP provides insufficient correction and risks volume overload. ATIII concentrate alone doesn't address protein C/S deficiency. The thrombosis risk is not theoretical, with rates of 10-15% in moderate-severe cases.", "generator_model": "kimi-k2-thinking", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "abms_specialty": "Pediatrics", "abms_source": "target_topic", "source_label_raw": "Pediatrics", "source_quiz_id": "20251219T234603131Z_kimi-k2-thinking_seed128", "source_question_id": "20251219T234603131Z_kimi-k2-thinking_seed128-001", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/kimi-k2-thinking/20251219T234603131Z_kimi-k2-thinking_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251219T234603131Z_kimi-k2-thinking_seed128.jsonl", "pred": "B", "model_outputs": "Prophylactic anticoagulation is indicated because PMM2-CDG commonly causes combined deficiencies of natural anticoagulants (antithrombin, protein C, protein S) and is associated with clinically significant thrombotic events, especially around surgery. \n\nFresh frozen plasma would not be appropriate because it provides procoagulant factors and is used for bleeding risk or factor deficiencies, not to prevent thrombosis in this context. Antithrombin concentrate alone would not address the protein C and S deficiencies and is generally reserved for patients with hereditary AT deficiency, particularly with prior thrombosis. Delaying surgery will not normalize these genetically determined deficiencies.\n\nPerioperative low-molecular-weight heparin prophylaxis is thus the best approach.\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_kimi-k2-thinking_p01", "question_id": "ABMS20260101_kimi-k2-thinking_p01-002", "question": "A 26-year-old woman ingests 60 mg of colchicine in a suicide attempt, presenting 8 hours later with profuse vomiting and diarrhea. Labs: WBC 22,000/μL, platelets 600,000/μL. Which intervention, when initiated within 12 hours of ingestion, has demonstrated mortality reduction in severe colchicine poisoning?", "options": ["Colchicine-specific Fab fragments 4 g IV bolus", "Granulocyte colony-stimulating factor 5 μg/kg/day subcutaneously", "Continuous venovenous hemofiltration at 50 mL/kg/hour", "N-acetylcysteine 150 mg/kg IV loading dose", "Plasma exchange daily for 5 days"], "answer": "B", "answer_index": 1, "explanation": "Early G-CSF administration reduces mortality by preventing septic complications from bone marrow suppression that begins 24-48 hours post-ingestion. Colchicine Fab (A) is experimental and unavailable. CVVH (C) does not enhance colchicine clearance due to large volume of distribution. NAC (D) has no role. Plasma exchange (E) is ineffective for intracellular toxins.", "generator_model": "kimi-k2-thinking", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "abms_specialty": "Emergency Medicine", "abms_source": "topics_mapped", "source_label_raw": "Emergency Medicine", "source_quiz_id": "20251205T080918850Z_kimi-k2-thinking_seed123", "source_question_id": "20251205T080918850Z_kimi-k2-thinking_seed123-005", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/kimi-k2-thinking/20251205T080918850Z_kimi-k2-thinking_seed123", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026_backup/20251205T080918850Z_kimi-k2-thinking_seed123.jsonl", "pred": "A", "model_outputs": "The answer is (A)"}, {"quiz_id": "ABMS20260101_kimi-k2-thinking_p01", "question_id": "ABMS20260101_kimi-k2-thinking_p01-003", "question": "A 32-year-old woman presents with irregular vaginal bleeding 18 months after an uncomplicated term delivery. Serum hCG is mildly elevated at 150 mIU/mL. Pelvic MRI demonstrates a 4 cm intrauterine mass. Endometrial biopsy reveals sheets of intermediate trophoblastic cells with eosinophilic cytoplasm, low mitotic index, and immunohistochemical staining strongly positive for hPL but negative for hCG. Which diagnosis is most likely?", "options": ["A) Choriocarcinoma", "B) Placental site trophoblastic tumor", "C) Epithelioid trophoblastic tumor", "D) Persistent hydatidiform mole", "E) Invasive mole"], "answer": "B", "answer_index": 1, "explanation": "Placental site trophoblastic tumor (PSTT) is a rare gestational trophoblastic disease derived from intermediate trophoblasts, characterized by hPL positivity and minimal hCG production. It presents months to years after pregnancy with mild hCG elevation and is relatively chemoresistant, often requiring hysterectomy. Choriocarcinoma and invasive mole have markedly elevated hCG and are hCG-positive on immunostain. Epithelioid trophoblastic tumor is even rarer and arises from chorionic-type intermediate trophoblasts.", "generator_model": "kimi-k2-thinking", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Obstetrics and Gynecology", "abms_specialty": "Obstetrics and Gynecology", "abms_source": "topics_mapped", "source_label_raw": "gynecology", "source_quiz_id": "20251205T080918850Z_kimi-k2-thinking_seed124", "source_question_id": "20251205T080918850Z_kimi-k2-thinking_seed124-002", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/kimi-k2-thinking/20251205T080918850Z_kimi-k2-thinking_seed124", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026_backup/20251205T080918850Z_kimi-k2-thinking_seed124.jsonl", "pred": "B", "model_outputs": "The answer is (B)"}, {"quiz_id": "ABMS20260101_kimi-k2-thinking_p01", "question_id": "ABMS20260101_kimi-k2-thinking_p01-004", "question": "A 28-year-old male with a dibucaine number of 20 (normal >70) and pseudocholinesterase activity of 0.2 U/mL (normal 0.5-1.2) requires emergency intubation for airway obstruction. After succinylcholine 1.5 mg/kg, apnea persists for 90 minutes. Which anesthetic agent should be avoided in future surgeries due to shared metabolic pathway?", "options": ["Rocuronium", "Ester local anesthetics (procaine, chloroprocaine)", "Vecuronium", "Cisatracurium", "Remifentanil"], "answer": "B", "answer_index": 1, "explanation": "A dibucaine number of 20 indicates homozygous atypical pseudocholinesterase. Succinylcholine and ester local anesthetics (procaine, chloroprocaine, tetracaine) are both metabolized by pseudocholinesterase. Aminosteroid relaxants (rocuronium, vecuronium) and benzylisoquinoliniums (cisatracurium) are not metabolized by this enzyme. Remifentanil is metabolized by non-specific esterases and is safe.", "generator_model": "kimi-k2-thinking", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "abms_specialty": "Anesthesiology", "abms_source": "target_topic", "source_label_raw": "Anesthesiology", "source_quiz_id": "20251219T234603131Z_kimi-k2-thinking_seed128", "source_question_id": "20251219T234603131Z_kimi-k2-thinking_seed128-006", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/kimi-k2-thinking/20251219T234603131Z_kimi-k2-thinking_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251219T234603131Z_kimi-k2-thinking_seed128.jsonl", "pred": "B", "model_outputs": "Patients with pseudocholinesterase deficiency have impaired metabolism of drugs hydrolyzed by plasma pseudocholinesterase, notably succinylcholine, mivacurium, and ester local anesthetics (e.g., procaine, chloroprocaine, tetracaine). These agents can cause prolonged effects and should be avoided.\n\nAmong the listed options, only ester local anesthetics share this metabolic pathway.\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_kimi-k2-thinking_p01", "question_id": "ABMS20260101_kimi-k2-thinking_p01-005", "question": "A 22-year-old female with systemic lupus erythematosus presents with nihilistic delusions that her organs have 'turned to dust' and that she is already dead. CSF shows lymphocytic pleocytosis and elevated protein. Which specific autoantibody is most strongly associated with this neuropsychiatric manifestation?", "options": ["Anti-dsDNA", "Anti-NR2A (NMDA receptor)", "Anti-Ro/SSA", "Anti-phospholipid", "Anti-Sm"], "answer": "B", "answer_index": 1, "explanation": "Anti-NR2A antibodies targeting NMDA receptors correlate strongly with diffuse neuropsychiatric SLE manifestations including psychosis, delusional states, and cognitive dysfunction. Anti-dsDNA is a general SLE marker without specific neuropsychiatric correlation. Anti-Ro is associated with neonatal lupus. Antiphospholipid antibodies cause thrombotic events. Anti-Sm is specific for SLE but not associated with particular neuropsychiatric features.", "generator_model": "kimi-k2-thinking", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "abms_specialty": "Psychiatry", "abms_source": "target_topic", "source_label_raw": "Psychiatry", "source_quiz_id": "20251219T234603131Z_kimi-k2-thinking_seed128", "source_question_id": "20251219T234603131Z_kimi-k2-thinking_seed128-008", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/kimi-k2-thinking/20251219T234603131Z_kimi-k2-thinking_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251219T234603131Z_kimi-k2-thinking_seed128.jsonl", "pred": "B", "model_outputs": "The answer is (B)"}, {"quiz_id": "ABMS20260101_kimi-k2-thinking_p01", "question_id": "ABMS20260101_kimi-k2-thinking_p01-006", "question": "A 58-year-old man with mid-rectal cancer (cT3N1M0) has enlarged right obturator lymph node (8 mm) on staging MRI. The primary tumor is 5 cm from the anal verge. What is the optimal treatment sequence?", "options": ["A) Long-course chemoradiation (50.4 Gy) followed by total mesorectal excision without lateral dissection", "B) Short-course radiation (25 Gy) followed by extended lymphadenectomy including obturator nodes", "C) Chemoradiation (50.4 Gy) with boost to obturator node, then TME with selective lateral dissection if node persists", "D) Induction chemotherapy (FOLFOX) followed by chemoradiation and TME", "E) Total neoadjuvant therapy with consolidation chemotherapy then TME with bilateral lateral lymph node dissection"], "answer": "C", "answer_index": 2, "explanation": "For rectal cancer with suspicious lateral lymph node, chemoradiation with simultaneous integrated boost (60 Gy to node) followed by TME with selective lateral dissection only for radiologically persistent nodes balances local control and morbidity. Prophylactic lateral dissection causes unnecessary urinary and sexual dysfunction. The Japanese JCOG0212 trial showed selective dissection is non-inferior to routine dissection when nodes respond to radiation.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "General Surgery", "abms_specialty": "General Surgery", "abms_source": "target_topic", "source_label_raw": "General Surgery", "source_quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "source_question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-011", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/kimi-k2-thinking/20251221T010349114Z_kimi-k2-thinking_seed130", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251221T010349114Z_kimi-k2-thinking_seed130.jsonl", "pred": "C", "model_outputs": "The answer is (C)"}, {"quiz_id": "ABMS20260101_kimi-k2-thinking_p01", "question_id": "ABMS20260101_kimi-k2-thinking_p01-007", "question": "A 3-year-old child with bilateral retinoblastoma has persistent class 3 vitreous seeds (vitreous clouds) in the right eye after six cycles of systemic chemotherapy and three intravitreal melphalan injections (30 µg). Examination shows tumor regression but diffuse non-confluent vitreous opacities. What is the next definitive management step?", "options": ["A) Increase intravitreal melphalan dose to 50 µg weekly for three doses", "B) Plaque brachytherapy with 125I to deliver 40 Gy to vitreous base", "C) Enucleation with histopathologic risk factor assessment", "D) Intravitreal topotecan 20 µg alternating with melphalan every 2 weeks", "E) External beam radiation therapy 45 Gy to entire globe"], "answer": "D", "answer_index": 3, "explanation": "For persistent class 3 vitreous seeds after standard melphalan, alternating intravitreal topotecan with melphalan provides synergistic tumoricidal activity while avoiding retinal toxicity from dose escalation. This protocol achieves 85% globe salvage for refractory seeds compared to 40% with continued melphalan alone, and avoids the late effects of external beam radiation in hereditary retinoblastoma.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Ophthalmology", "abms_specialty": "Ophthalmology", "abms_source": "target_topic", "source_label_raw": "Ophthalmology", "source_quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "source_question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-003", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/kimi-k2-thinking/20251221T010349114Z_kimi-k2-thinking_seed130", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251221T010349114Z_kimi-k2-thinking_seed130.jsonl", "pred": "D", "model_outputs": "The answer is (D)"}, {"quiz_id": "ABMS20260101_kimi-k2-thinking_p01", "question_id": "ABMS20260101_kimi-k2-thinking_p01-008", "question": "A 78-year-old woman falls and sustains a four-part proximal humerus fracture with head-split pattern and 2 cm medial calcar comminution. The greater tuberosity is fractured but not displaced. What is the optimal implant selection?", "options": ["A) Open reduction and internal fixation with locking plate and fibular allograft augmentation", "B) Hemiarthroplasty with cemented stem and tuberosity repair", "C) Reverse shoulder arthroplasty with 36 mm glenosphere and augmented baseplate", "D) Reverse shoulder arthroplasty with standard baseplate and tuberosity preservation", "E) Nonoperative management with sling and early passive motion"], "answer": "D", "answer_index": 3, "explanation": "In elderly patients with head-split fractures and intact tuberosities, reverse shoulder arthroplasty with standard baseplate and tuberosity preservation (not repair) provides superior forward elevation and reduces prosthetic instability. Augmented baseplates are unnecessary without glenoid bone loss, and tuberosity repair in reverse arthroplasty increases stiffness without functional benefit. ORIF has 60% failure rate in this pattern, and hemiarthroplasty requires functional rotator cuff.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Orthopedic Surgery", "abms_specialty": "Orthopedic Surgery", "abms_source": "target_topic", "source_label_raw": "Orthopedic Surgery", "source_quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "source_question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-014", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/kimi-k2-thinking/20251221T010349114Z_kimi-k2-thinking_seed130", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251221T010349114Z_kimi-k2-thinking_seed130.jsonl", "pred": "D", "model_outputs": "The optimal choice is reverse shoulder arthroplasty designed for fracture, with preservation and repair of the tuberosities and a standard baseplate on a normal glenoid. Augmented baseplates are used for glenoid deformity (e.g., B2) rather than acute fractures.\n\nThe answer is (D)"}, {"quiz_id": "ABMS20260101_kimi-k2-thinking_p01", "question_id": "ABMS20260101_kimi-k2-thinking_p01-009", "question": "A 45-year-old with severe ARDS on VV-ECMO develops suspected heparin-induced thrombocytopenia (4T score 6). Heparin is discontinued and argatroban initiated. The patient has significant hemolysis (plasma free hemoglobin 800 mg/dL). Which monitoring assay is most reliable for titrating argatroban in this setting?", "options": ["Activated partial thromboplastin time (aPTT)", "Anti-Xa chromogenic assay", "Anti-IIa (thrombin) chromogenic assay", "Activated clotting time (ACT)", "Dilute Russell viper venom time (dRVVT)"], "answer": "C", "answer_index": 2, "explanation": "Anti-IIa chromogenic assay directly measures thrombin inhibition by argatroban and is least affected by hemolysis, platelet count, or factor consumption seen in ECMO. aPTT is unreliable due to factor deficiency and hemolysis. Anti-Xa assays measure anti-Xa activity, not direct thrombin inhibitors. ACT is affected by platelets and fibrinogen. dRVVT is used for lupus anticoagulant detection.", "generator_model": "kimi-k2-thinking", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Critical Care Medicine", "abms_specialty": "Critical Care Medicine", "abms_source": "topics_mapped", "source_label_raw": "critical care", "source_quiz_id": "20251205T080918850Z_kimi-k2-thinking_seed125", "source_question_id": "20251205T080918850Z_kimi-k2-thinking_seed125-001", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/kimi-k2-thinking/20251205T080918850Z_kimi-k2-thinking_seed125", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026_backup/20251205T080918850Z_kimi-k2-thinking_seed125.jsonl", "pred": "A", "model_outputs": "Argatroban is typically titrated using a clot-based assay, most commonly the aPTT. In the presence of marked hemolysis, chromogenic assays (anti-Xa, anti-IIa) become unreliable due to optical interference from free hemoglobin, making aPTT the most reliable option here.\n\nThe answer is (A)"}, {"quiz_id": "ABMS20260101_kimi-k2-thinking_p01", "question_id": "ABMS20260101_kimi-k2-thinking_p01-010", "question": "A 42-year-old man with a heterozygous CSF1R p.Arg782His mutation and early-stage adult-onset leukoencephalopathy with axonal spheroids (ALSP) has mild cognitive impairment and gait instability. His sister progressed to severe dementia within 3 years of symptom onset. Which intervention has demonstrated the highest disease-modifying efficacy when performed before onset of severe motor disability?", "options": ["Intravenous immunoglobulin monthly", "Oral cyclophosphamide 2 mg/kg/day", "Allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor", "Ruxolitinib 20 mg twice daily", "Supportive care with donepezil"], "answer": "C", "answer_index": 2, "explanation": "Allogeneic HSCT is the only intervention shown to halt ALSP progression when performed early, before severe disability, by replacing microglial precursors. IVIG (A) and cyclophosphamide (B) lack efficacy. Ruxolitinib (D) has no clinical data. Supportive care (E) does not modify disease course. Delay until severe motor impairment predicts transplant failure.", "generator_model": "kimi-k2-thinking", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurology", "abms_specialty": "Neurology", "abms_source": "topics_mapped", "source_label_raw": "Neurology", "source_quiz_id": "20251205T080918850Z_kimi-k2-thinking_seed123", "source_question_id": "20251205T080918850Z_kimi-k2-thinking_seed123-002", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/kimi-k2-thinking/20251205T080918850Z_kimi-k2-thinking_seed123", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026_backup/20251205T080918850Z_kimi-k2-thinking_seed123.jsonl", "pred": "C", "model_outputs": "The answer is (C)"}]